Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01262833 · ClinicalTrials.gov registry record
Pudendal Assessment in Erectile Dysfunction
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 10
- Enrollment target
NCT01262833: Clinical Trial study, sponsored by University of Pennsylvania.
NCT01262833 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01262833 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The study will address the role of internal pudendal artery disease in erectile dysfunction (ED), and whether it might eventually be amenable to intervention with stenting. There is currently a small trial investigating the potential benefit of stenting for erectile dysfunction, but the relationship between pelvic arterial stenoses and erectile dysfunction is not yet proven. The investigators intend to perform angiography on patients both with and without erectile dysfunction, to see whether internal pudendal artery disease is more common in the population with erectile dysfunction. In addition to angiography, stenoses will be examined using fractional flow reserve. The degree of internal pudendal artery disease will then be correlated with the degree of erectile dysfunction using a validated questionnaire, the International Index of Erectile Function (IIEF). Patients will then complete IIEF questionnaires for 5 years to assess the relationship between internal pudendal artery disease and progression of erectile dysfunction.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01262833
The ClinicalTrials.gov registry entry for NCT01262833 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01262833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01262833 about?
NCT01262833 is a clinical study titled "Pudendal Assessment in Erectile Dysfunction". The study will address the role of internal pudendal artery disease in erectile dysfunction (ED), and whether it might eventually be amenable to intervention with stenting. There is currently a small trial investigating the potential benefit of stenting for erectile dysfunction, but the relationship...
What is the current status of trial NCT01262833?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2010-09. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT01262833?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.